Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

<strong>Background<br></strong> The influence of renin–angiotensin–aldosterone system (RAAS) inhibitors on the critically ill COVID-19 patients with pre-existing hypertension remains uncertain. This study examined the impact of previous use of angiotensin-converting enzyme inhibito...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Sato, K, White, N, Fanning, JP, Obonyo, N, Yamashita, MH, Appadurai, V, Ciullo, A, May, M, Worku, ET, Helms, L, Ohshimo, S, Juzar, DA, Suen, JY, Bassi, GL, Fraser, JF, Arora, RC, Nichol, A
Andere auteurs: COVID-19 Critical Care Consortium Investigators
Formaat: Journal article
Taal:English
Gepubliceerd in: BioMed Central 2022

Gelijkaardige items